HYBRID EVENT: You can participate in person at Singapore or Virtually from your home or work.

4th Edition of

International Ophthalmology Conference

March 23-25, 2026 | Singapore

IOC 2026

Preclinical evaluation of optogenetic therapy by clinically relevant multi-luminance behavioral test

Speaker at International Ophthalmology Conference 2026 - Xueting Luo
UgeneX, China
Title : Preclinical evaluation of optogenetic therapy by clinically relevant multi-luminance behavioral test

Abstract:

Abstract
Optogenetic therapy holds great potential for treatment of late-stage photoreceptor degenerative diseases. However, clinical translation of such therapeutic candidates is usually impeded by inconsistency in evaluation of visual function between preclinical models and clinical practice. To address this gap, we have developed a multi-luminance behavioural test (MLBT) to measure visual function of preclinical pathogenic models. Specifically, murine models for photoreceptor degeneration were evaluated in a light-dark box under various illumination levels according to real-life situations. In this way, a threshold for illumination level with therapeutic efficacy could be determined for optogenetic therapy candidates. MLBT of preclinical animal models treated by optogenetic therapy allows objective evaluation of light sensitivity for different therapy candidates in a more clinically relevant situation. Translatability of MLBT in preclinical models for optogenetic therapy will be evaluated in upcoming clinical trials.

Biography:

Dr. Luo received her PhD in Molecular Biology in 2011 at University of Miami. After four years postdoctoral fellowship at the same institute, he then joined Shanghai General Hospital as researcher at Department of Ophthalmology. After five years, Dr. Luo moved to pharmaceutical industry and worked at different companies with increasing roles and responsibilities. Currently, he served as VP of Discovery at UgeneX Biotechnology, focusing on developing innovative gene therapy for ophthalmology diseases. Dr. Luo has published more than 50 research articles in SCI journals.

Watsapp